| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.02B | 38.25B | 33.21B | 27.68B | 24.17B | 19.74B |
| Gross Profit | 12.57B | 14.90B | 11.69B | 10.78B | 9.25B | 7.51B |
| EBITDA | 7.60B | 4.49B | 7.03B | 6.37B | 5.36B | 3.18B |
| Net Income | 2.81B | 2.74B | 2.40B | 3.54B | 1.81B | 1.08B |
Balance Sheet | ||||||
| Total Assets | 37.20B | 43.80B | 32.72B | 25.31B | 22.73B | 15.08B |
| Cash, Cash Equivalents and Short-Term Investments | 4.62B | 8.10B | 4.33B | 4.51B | 3.70B | 2.28B |
| Total Debt | 17.99B | 20.91B | 13.20B | 9.97B | 11.66B | 6.09B |
| Total Liabilities | 24.78B | 29.44B | 20.25B | 14.88B | 15.84B | 9.32B |
| Stockholders Equity | 12.42B | 14.36B | 12.47B | 10.43B | 6.89B | 5.75B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.10B | 4.03B | 4.70B | 3.63B | 1.10B |
| Operating Cash Flow | 0.00 | 7.19B | 4.94B | 5.39B | 4.19B | 1.69B |
| Investing Cash Flow | 0.00 | -7.10B | -6.61B | -1.20B | -3.00B | -2.76B |
| Financing Cash Flow | 0.00 | 3.58B | 1.53B | -3.38B | 225.00M | 2.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥16.06B | 13.11 | ― | 3.96% | 12.90% | -7.43% | |
69 Neutral | ¥14.52B | 11.58 | ― | 2.51% | 9.38% | 246.38% | |
63 Neutral | ¥57.53B | 20.41 | ― | 0.70% | 15.15% | 15.26% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | ¥1.32B | 9.33 | ― | 3.86% | 7.65% | 38.96% | |
40 Underperform | ¥3.81B | -22.11 | ― | ― | -6.70% | 83.83% |